Control of an outbreak of carbapenem-resistant Pseudomonas aeruginosa in a haemato-oncology unit

Journal of Hospital Infection

Volumn 79, Issue 1, 2011, Pages 49-53

  Nagao, M ^a,b   Iinuma, Y ^c   Igawa, J ^a,b   Saito, T ^d   Yamashita, K ^a   Kondo, T ^a   Matsushima, A ^a,b   Takakura, S ^a,b   Takaori Kondo, A ^a   Ichiyama, S ^a,b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

^d Shiga Medical Center for Adults   (Japan)

Author keywords

Metallo lactamase; Outbreak; Pseudomonas aeruginosa

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; COLISTIN; METALLO BETA LACTAMASE; QUINOLONE DERIVATIVE;

ARTICLE; BACTERIAL STRAIN; BLOODSTREAM INFECTION; CASE CONTROL STUDY; CHOLANGITIS; CLEANING; CLINICAL ARTICLE; EPIDEMIC; HOSPITAL SUBDIVISIONS AND COMPONENTS; HUMAN; INCIDENCE; INFECTION CONTROL; JAPAN; MULTIDRUG RESISTANCE; PNEUMONIA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SINUSITIS; SKIN INFECTION; SOFT TISSUE INFECTION; TERTIARY HEALTH CARE; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; INFECTION CONTROL; JAPAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 80051473679     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.04.018     Document Type: Article

References (26)

1. Kohlenberg A., Schwab F., Geffers C., et al. Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between 2000 and 2005. Clin Microbiol Infect 2008, 14:93-96.
2. Chatzinikolaou I., Abi-Said D., Bodey G.P., Rolston K.V., Tarrand J.J., Samonis G. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: retrospective analysis of 245 episodes. Arch Intern Med 2000, 160:501-509.
3. Moolenaar R.L., Crutcher J.M., San Joaquin V.H., et al. A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission?. Infect Control Hosp Epidemiol 2000, 21:80-85.
4. Muscarella L.F. Contribution of tap water and environmental surfaces to nosocomial transmission of antibiotic-resistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol 2004, 25:342-345.
5. Iversen B.G., Jacobsen T., Eriksen H.M., et al. An outbreak of Pseudomonas aeruginosa infection caused by contaminated mouth swabs. Clin Infect Dis 2007, 44:794-801.
6. Mesaros N., Nordmann P., Plesiat P., et al. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect 2007, 13:560-578.
7. Kouda S., Ohara M., Onodera M., et al. Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the blaIMP-1 gene cassette in Hiroshima. J Antimicrob Chemother 2009, 64:46-51.
8. Lautenbach E., Weiner M.G., Nachamkin I., Bilker W.B., Sheridan A., Fishman N.O. Imipenem resistance among Pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes. Infect Control Hosp Epidemiol 2006, 27:893-900.
9. Elias J., Shoen C., Heinze G., et al. Nosocomial outbreak of VIM-2 metallo-beta-lactamase producing Pseudomonas aeruginosa associated with retrograde urography. Clin Microbiol Infect 2010, 16:1494-1500.
10. Kolenberg A., Weitzel-Kage D., Linden P., et al. Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit. J Hosp Infect 2010, 74:350-357.
11. Performance standards for antimicrobial susceptibility testing: 16th informational supplement. CLSI document M100-S16 2006, Clinical and Laboratory Standards Institute, CLSI, Wayne, PA.
12. Pitout J.D.D., Gregson D.B., Poirel L., McClure J.A., Le P., Church D.L. Detection of Pseudomonas aeruginosa producing metallo-beta-lactamases in a large centralized laboratory. J Clin Microbiol 2005, 43:3129-3135.
13. Ohara M., Kouda S., Onodera M., et al. Molecular characterization of imipenem-resistant Pseudomonas aeruginosa in Hiroshima, Japan. Microbiol Immunol 2007, 51:271-277.
14. Clancy M., Graepler A., Wilson M., Douglas I., Johnson J., Price C.S. Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital. Infect Control Hosp Epidemiol 2006, 27:1009-1017.
15. Jernigan J.A., Clemence M.A., Stott G.A., et al. Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995, 16:686-696.
16. West T.E., Guerry C., Hiott M., Morrow N., Ward K., Salgado C.D. Effect of targeted surveillance for control of methicillin-resistant Staphylococcus aureus in a community hospital system. Infect Control Hosp Epidemiol 2006, 27:233-238.
17. Laurent C., Rodriguez-Villalobos H., Rost F., et al. Intensive care unit outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures. Infect Control Hosp Epidemiol 2008, 29:517-524.
18. Peña C., Pujol M., Ardanuy C., et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1998, 42:53-58.
19. Ben-David D., Maor Y., Keller N., et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 2010, 31:620-626.
20. Chaix C., Durand-Zaleski I., Alberti C., Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999, 282:1745-1751.
21. Harbarth S., Frankhouser C., Schrenzel J., et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008, 299:1149-1157.
22. Pakyz A., Oinonen M., Polk R. Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009, 53:1983-1986.
23. Hirakata Y., Yamaguchi T., Nakano M., et al. Clinical and bacteriological characteristics of IMP-type metallo-β-lactamase-producing Pseudomonas aeruginosa. Clin Infect Dis 2003, 37:26-32.
24. Richard P., Le Floch R., Chamoux C., Pannier M., Espaze E., Richet H. Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains. J Infect Dis 1994, 170:377-383.
25. Paramythiotou E., Lucet J.C., Timsit J.F., et al. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. Clin Infect Dis 2004, 38:670-677.
26. Kanda J., Ichinohe T., Saito T., et al. Impact of discontinuing fluoroquinolone prophylaxis on early mortality after allogeneic marrow or peripheral blood SCT with myeloablative conditioning. Bone Marrow Transplant 2010, 45:1369-1371.